WITNESSETH:Lease Agreement • April 16th, 1999 • United Therapeutics Corp
Contract Type FiledApril 16th, 1999 Company
RECITALSEscrow Agreement • February 1st, 2001 • United Therapeutics Corp • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 1st, 2001 Company Industry Jurisdiction
ESCROW AGREEMENTEscrow Agreement • February 1st, 2001 • United Therapeutics Corp • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 1st, 2001 Company Industry Jurisdiction
1 STOCK PURCHASE AGREEMENT United Therapeutics Corporation 1110 Spring Street Silver Spring, MD 20910 Ladies and Gentlemen: The undersigned, _________________________________(the "Investor"), hereby confirms its agreement with you as follows: 1. This...Stock Purchase Agreement • July 14th, 2000 • United Therapeutics Corp • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 14th, 2000 Company Industry Jurisdiction
ARTICLE II REPRESENTATIONS AND WARRANTIESCommon Stock Purchase Agreement • April 16th, 1999 • United Therapeutics Corp • Delaware
Contract Type FiledApril 16th, 1999 Company Jurisdiction
1 RIGHTS AGREEMENT UNITED THERAPEUTICS CORPORATIONRights Agreement • December 18th, 2000 • United Therapeutics Corp • Pharmaceutical preparations • New York
Contract Type FiledDecember 18th, 2000 Company Industry Jurisdiction
1 EXHIBIT 10.4 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this "Agreement") is entered into as of July 15, 1996 by and between Lung Rx, Inc., a Delaware corporation having its principal offices at 1824 R Street, N.W., Washington, D.C. 20009 (the...Employment Agreement • April 16th, 1999 • United Therapeutics Corp • District of Columbia
Contract Type FiledApril 16th, 1999 Company Jurisdiction
WARRANT TO PURCHASE 350,000 SHARES OF THE COMMON STOCK, PAR VALUE $00.01 PER SHARE, OF UNITED THERAPEUTICS CORPORATIONUnited Therapeutics Corp • April 16th, 1999
Company FiledApril 16th, 1999
EXECUTIVE EMPLOYMENT AGREEMENT (AS AMENDED)Employment Agreement • April 16th, 1999 • United Therapeutics Corp • Maryland
Contract Type FiledApril 16th, 1999 Company Jurisdiction
EXHIBIT 10.15 MANUFACTURING AGREEMENT AGREEMENT dated as of February 11, 1998 by and between UNITED THERAPEUTICS CORPORATION ("UNITED THERAPEUTICS"), a Delaware corporation with principal offices at 1826 R Street NW, Washington DC 20009 and Steroids,...Manufacturing Agreement • June 15th, 1999 • United Therapeutics Corp • Pharmaceutical preparations • District of Columbia
Contract Type FiledJune 15th, 1999 Company Industry Jurisdiction
EXHIBIT 4.2 REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 16th, 1999 • United Therapeutics Corp • Delaware
Contract Type FiledApril 16th, 1999 Company Jurisdiction
3- 4 the Company or any Subsidiary or over their respective properties is required for the execution and delivery of this Agreement or the consummation of the transactions contemplated by this Agreement, except for compliance with the Blue Sky laws,...Form of Purchase Agreement • December 30th, 1999 • United Therapeutics Corp • Pharmaceutical preparations • New York
Contract Type FiledDecember 30th, 1999 Company Industry Jurisdiction
RECITALSIndemnification Agreement • April 16th, 1999 • United Therapeutics Corp • Maryland
Contract Type FiledApril 16th, 1999 Company Jurisdiction
AGREEMENT AND PLAN OF MERGER among UNITED THERAPEUTICS CORPORATION, DANIEL 24043 ACQUISITION CORP. LTD.Agreement and Plan of Merger • May 1st, 2018 • UNITED THERAPEUTICS Corp • Pharmaceutical preparations • Delaware
Contract Type FiledMay 1st, 2018 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of April 29, 2018, by and among United Therapeutics Corporation, a Delaware corporation (“Parent”), Daniel 24043 Acquisition Corp. Ltd., a company organized under the laws of the State of Israel and a wholly-owned Subsidiary of Parent (“Merger Sub”) and SteadyMed Ltd., a company organized under the laws of the State of Israel (the “Company”).
RECITALSAsset Purchase Agreement • February 1st, 2001 • United Therapeutics Corp • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 1st, 2001 Company Industry Jurisdiction
LEASELease • April 16th, 1999 • United Therapeutics Corp • District of Columbia
Contract Type FiledApril 16th, 1999 Company Jurisdiction
1 EXHIBIT 10.2 REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 15th, 1999 • United Therapeutics Corp • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 15th, 1999 Company Industry Jurisdiction
EXHIBIT 10.1 AGREEMENT AND PLAN OF MERGER OCTOBER 7, 1999Agreement and Plan of Merger • November 15th, 1999 • United Therapeutics Corp • Pharmaceutical preparations • New York
Contract Type FiledNovember 15th, 1999 Company Industry Jurisdiction
RECITALSAsset Purchase Agreement • February 1st, 2001 • United Therapeutics Corp • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 1st, 2001 Company Industry Jurisdiction
WITNESSETH:Exclusive License Agreement • April 16th, 1999 • United Therapeutics Corp • New York
Contract Type FiledApril 16th, 1999 Company Jurisdiction
CREDIT AGREEMENT dated as of September 26, 2013 by and among UNITED THERAPEUTICS CORPORATION, as Borrower, THE SUBSIDIARIES OF THE BORROWER IDENTIFIED HEREIN, as the Guarantors the Lenders referred to herein, as Lenders, and WELLS FARGO BANK, NATIONAL...Credit Agreement • September 27th, 2013 • UNITED THERAPEUTICS Corp • Pharmaceutical preparations • New York
Contract Type FiledSeptember 27th, 2013 Company Industry JurisdictionCREDIT AGREEMENT, dated as of September 26, 2013, by and among UNITED THERAPEUTICS CORPORATION, a Delaware corporation, as Borrower, certain Subsidiaries (as hereinafter defined) of the Borrower who are or may become party to this Agreement from time to time, as Guarantors, the lenders who are or may become party to this Agreement from time to time, as Lenders, and WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association, as Administrative Agent for the Lenders.
Common StockUnited Therapeutics Corp • April 16th, 1999 • Maryland
Company FiledApril 16th, 1999 Jurisdiction
EMPLOYMENT AGREEMENTEmployment Agreement • May 14th, 2002 • United Therapeutics Corp • Pharmaceutical preparations • Illinois
Contract Type FiledMay 14th, 2002 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of October 22, 1999 by and between SynQuest, Inc., an Illinois corporation having its principal offices at 2225 W. Harrison, Chicago, Illinois 60612 (the “Company”) and David Walsh, Ph.D. (the “Executive”).
EXHIBIT 10.8 EXCLUSIVE LICENSE AGREEMENT THIS AGREEMENT effective as of this 3rd day of December, 1996, between LUNG RX, Inc., a corporation organized and existing under the laws of the State of Delaware, with its principal place of business at 100...Exclusive License Agreement • June 10th, 1999 • United Therapeutics Corp • Pharmaceutical preparations • Michigan
Contract Type FiledJune 10th, 1999 Company Industry Jurisdiction
EXHIBIT 10.14 EXCLUSIVE LICENSE AGREEMENT This Exclusive License Agreement ("Agreement") is effective as of March 15, 1999 (the "Effective Date"), by and between United Therapeutics Corporation, a Delaware corporation, having an address at 68 T.W....Exclusive License Agreement • June 10th, 1999 • United Therapeutics Corp • Pharmaceutical preparations • New York
Contract Type FiledJune 10th, 1999 Company Industry Jurisdiction
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • April 28th, 2016 • UNITED THERAPEUTICS Corp • Pharmaceutical preparations • Delaware
Contract Type FiledApril 28th, 2016 Company Industry JurisdictionThis Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Michael Benkowitz (the “Employee”) and United Therapeutics Corporation, a Delaware corporation (the “Company”), effective as of February 14, 2012 (the “Effective Date”).
FIRST AMENDED AND RESTATED RIGHTS AGREEMENT UNITED THERAPEUTICS CORPORATION and THE BANK OF NEW YORK Rights Agent Dated as of June 30, 2008Rights Agreement • July 3rd, 2008 • United Therapeutics Corp • Pharmaceutical preparations • New York
Contract Type FiledJuly 3rd, 2008 Company Industry JurisdictionThis First Amended and Restated Rights Agreement, dated as of June 30, 2008 is entered into between United Therapeutics Corporation, a Delaware corporation (the “Company”), and The Bank of New York, a New York banking corporation (the “Rights Agent”).
AMENDED AND RESTATED DISTRIBUTION AGREEMENTDistribution Agreement • February 24th, 2011 • UNITED THERAPEUTICS Corp • Pharmaceutical preparations • New York
Contract Type FiledFebruary 24th, 2011 Company Industry JurisdictionTHIS AMENDED AND RESTATED DISTRIBUTION AGREEMENT (“Agreement”) is made as of February 21, 2011 (the “Effective Date”), by and between United Therapeutics Corporation (“UT”), a Delaware corporation, with offices at 1040 Spring Street, Silver Spring, Maryland and Accredo Health Group, Inc. (“DISTRIBUTOR”), a Delaware corporation, with offices at 1640 Century Center Parkway, Memphis, Tennessee 38134.
ASSET PURCHASE AGREEMENT BY AND BETWEEN ABBVIE IRELAND UNLIMITED COMPANY AND UNITED THERAPEUTICS CORPORATION August 18, 2015Asset Purchase Agreement • August 19th, 2015 • UNITED THERAPEUTICS Corp • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 19th, 2015 Company Industry JurisdictionThis ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of August 18, 2015 (“Effective Date”), by and between AbbVie Ireland Unlimited Company, a private unlimited company incorporated under the laws of Ireland (“Buyer”), and United Therapeutics Corporation, a Delaware corporation (“Seller”). Buyer and Seller may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.
LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • August 3rd, 2022 • UNITED THERAPEUTICS Corp • Pharmaceutical preparations • New York
Contract Type FiledAugust 3rd, 2022 Company Industry JurisdictionThis License and Collaboration Agreement (the “Agreement”) is entered into as of September 3, 2018 (the “Execution Date”) between MannKind Corporation, a Delaware corporation (“MannKind”), having a principal place of business at 30930 Russell Ranch Road, Suite 301, Westlake Village, California 91362, and United Therapeutics Corporation, a Delaware corporation (“United Therapeutics”), having a principal place of business at 1040 Spring Street, Silver Spring, Maryland 20910.
COMMERCIALIZATION AGREEMENTCommercialization Agreement • February 27th, 2019 • UNITED THERAPEUTICS Corp • Pharmaceutical preparations • Minnesota
Contract Type FiledFebruary 27th, 2019 Company Industry JurisdictionThis Commercialization Agreement (this “Agreement”) is made as of the date last signed by the Parties (the “Effective Date”), by and between United Therapeutics Corporation, a corporation incorporated under the laws of Delaware and having a place of business at 55 T.W. Alexander Drive, Research Triangle Park, North Carolina 27709 (“UT”), and Medtronic, Inc., a corporation incorporated under the laws of the State of Minnesota and having its place of business at 8200 Coral Sea Street NE, Mounds View, Minnesota 55112 (“Medtronic”), each a “Party”, collectively the “Parties.”
AMENDMENT NO. 2 TO CREDIT AGREEMENTCredit Agreement • July 28th, 2015 • UNITED THERAPEUTICS Corp • Pharmaceutical preparations • New York
Contract Type FiledJuly 28th, 2015 Company Industry JurisdictionTHIS AMENDMENT NO. 2 TO CREDIT AGREEMENT dated as of July 24, 2015 (as amended, restated, supplemented or otherwise modified from time to time this “Amendment”), is entered into by and among UNITED THERAPEUTICS CORPORATION, a Delaware corporation, as Borrower, certain Subsidiaries of the Borrower who are or may become party to the Credit Agreement from time to time, as Guarantors, the lenders who are or may become party to the Credit Agreement from time to time, as Lenders, and WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association, as Administrative Agent for the Lenders.
AGENCY AGREEMENT Dated as of June 28, 2004 between UNITED THERAPEUTICS CORPORATION, as the Construction Agent, and WACHOVIA DEVELOPMENT CORPORATION, as the LessorAgency Agreement • July 6th, 2004 • United Therapeutics Corp • Pharmaceutical preparations • New York
Contract Type FiledJuly 6th, 2004 Company Industry JurisdictionTHIS AGENCY AGREEMENT, dated as of June 28, 2004 (as amended, modified, extended, supplemented, restated and/or replaced from time to time, the “Agreement”), is between WACHOVIA DEVELOPMENT CORPORATION, a North Carolina corporation (the “Lessor”) and UNITED THERAPEUTICS CORPORATION, a Delaware corporation (the “Construction Agent”).
RECITALSCooperation and Strategic Alliance Agreement • June 11th, 1999 • United Therapeutics Corp • Pharmaceutical preparations • California
Contract Type FiledJune 11th, 1999 Company Industry Jurisdiction
EXCLUSIVE LICENSE AGREEMENT by and between Arena Pharmaceuticals, Inc. (“Arena”) United Therapeutics Corporation (“UT”) DATED AS OF NOVEMBER 15, 2018Exclusive License Agreement • January 25th, 2019 • UNITED THERAPEUTICS Corp • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 25th, 2019 Company Industry JurisdictionTHIS EXCLUSIVE LICENSE AGREEMENT (this “Agreement”) is made as of November 15, 2018, by and between Arena Pharmaceuticals, Inc., a Delaware corporation (“Arena”), and United Therapeutics Corporation, a Delaware corporation (“UT,” and with Arena, each a “Party” and, together, the “Parties”).